The Effect of Cabergoline on Clinical and Laboratory Findings in Active Rheumatoid Arthritis

@inproceedings{Mobini2011TheEO,
  title={The Effect of Cabergoline on Clinical and Laboratory Findings in Active Rheumatoid Arthritis},
  author={M. D. Mahdi Mobini and Zahra Kashi and A R Mohammad Pour and Elaham Adibi},
  booktitle={Iranian Red Crescent medical journal},
  year={2011}
}
Dear Editor, Rheumatoid arthritis (RA) is a chronic systemic in-flammatory disorder affecting about 1% of the world population. 1 In recent years, biologic agents were introduced for many aspects of medicine including RA, but their cost and potential side effects prohibited its widespread use. Dopamine agonists such as bromocriptine and cabergoline decreased the prolactin synthesis and secretion by binding of the drug to cell-surface dopa-mine receptors. 2 Prolactin is secreted not only by… CONTINUE READING